Back to AI Alyeska Investment Group, L.P.
SLSShowing 0 of 6 quarters
Position history for AIAlyeska Investment Group, L.P.'s holdings in SELLAS LIFE SCIENCES GROUP I
No. Alyeska Investment Group exited its SLS (Sellas Life Sciences Group) position in Q4 2023. Its Q3 2023 13F listed 640,011 shares worth $1M. Alyeska Investment Group first reported SLS in Q2 2022 and held it in 4 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of SLS: BlackRock, Inc., STATE STREET CORP, VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC